37 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
27 Nov 23
Regulation FD Disclosure
7:07am
at Autolus for their support, trust and commitment for the program to reach this important milestone.” Autolus plans to submit a Marketing
6-K
AUTL
Autolus Therapeutics plc
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
and its subsequent filings with the U.S. Securities and Exchange Commission. The Company makes no commitment to revise or update any forward-looking
F-1/A
EX-10.3
AUTL
Autolus Therapeutics plc
19 Jun 18
Registration statement (foreign) (amended)
8:05am
sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby Participant has … . If, for any reason, such “same day sale” commitment pursuant to Section 3.3(b) does not result in sufficient proceeds to satisfy the Withholding Taxes
S-8
EX-99.4
AUTL
Autolus Therapeutics plc
31 Jul 18
Registration of securities for employees
4:09pm
, pursuant to Section 3.3(b), Participant has agreed to a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry … directly to the Company and/or its parents or subsidiaries. If, for any reason, such “same day sale” commitment pursuant to Section 3.3(b) does
F-1/A
EX-10.3
AUTL
Autolus Therapeutics plc
8 Jun 18
Registration statement (foreign) (amended)
6:25am
(the “Withholding Taxes”). Specifically, pursuant to Section 3.3(b), Participant has agreed to a “same day sale” commitment with a broker-dealer … ” commitment pursuant to Section 3.3(b) does not result in sufficient proceeds to satisfy the Withholding Taxes or would be prohibited by Applicable Laws
6-K
EX-99.4
fp1l7 eog1np2co
8 Nov 21
Securities Purchase Agreement
5:28pm
F-1
EX-10.1
akmtv 20z
7 May 18
Registration statement (foreign)
4:45pm
F-1/A
EX-10.1
ajjvmkn hc7a0d
10 May 18
Registration statement (foreign) (amended)
5:19pm
10-Q
EX-10.2
h48 gkcz2239m
9 Nov 23
Quarterly report
4:18pm
20-F
EX-2.3
07mvv7rk ql59g6
23 Nov 18
Annual report (foreign)
12:00am
8-K
EX-10.1
k7b8j2 okjvpi
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
6-K
EX-99.1
xa4poe6q
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1
6wovinaj37dgv5
1 Jul 22
Current report (foreign)
5:15pm
8-K
EX-1.1
3hi1efmq6cuam
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
6-K
EX-1.1
083jl
24 Jan 20
Autolus Announces Proposed Public Offering in the United States
4:06pm
F-1
EX-1.1
rvh9tnya0e893w0mxfe
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-1.1
4kko2
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
oaxpl4dy
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am